Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient willing for clinical trial and ready to give written Consent. 2. Patients between the age group of 30-60 years of either sex. 3. Patients fulfill the diagnostic criteria of Tamaka Shwasa (Bronchial Asthma). 4. Patients presented with cardinal features of Tamaka Shwasa as described in Ayurveda texts. 5. Newly Diagnosed and confirmed cases of Tamaka Shawasa (Bronchial Asthma) on the basis of criteria given by NAEPP.
Exclusion criteria
Exclusion criteria: 1. Patient not willing to Clinical Trial 2. Patients not fulfilling the Inclusion Criteria 3. Patient having an Age below 30 and Above 60. 4. Patients having a medical history of CHF, CAD, Pulmonary hypertension, Diabetes Mellitus, Uncontrolled hypertension, CKD, and Autoimmune disorders. 5. During Pregnancy, Lactation period. 6. 7. Patients on Steroid therapy, Inhaler or any other medicines. Patient Suffering from Secondary Respiratory Disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Improvement in lung function: Measure changes in FEV1 (Forced Expiratory Volume in 1second),FVC,FVR or PEFR (Peak Expiratory Flow Rate). 2. Change in intensity and severity of Rhonchi and Wheeze. 3.Change in intensity and severity in the symptoms of Tamaka Shwasa.Timepoint: 21 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the effect of the interventions on biochemical markers such as absolute eosinophil count and inflammatory indices(ESR and CRP). 2. Exacerbation frequency: Track changes in frequency of asthma exacerbations.Timepoint: 21 Days | — |
Countries
India
Contacts
Institute For Ayurved Studies and Research Shri Krishna AYUSH University